600079 人福医药
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)9.10713.30717.75311.1689.675
总资产报酬率 ROA (%)4.3235.9106.9553.8842.983
投入资产回报率 ROIC (%)5.6577.8039.1795.0094.061

边际利润分析
销售毛利率 (%)46.75845.80643.52542.74741.975
营业利润率 (%)13.87314.05615.74010.94510.115
息税前利润/营业总收入 (%)15.23415.03916.39813.60814.233
净利润/营业总收入 (%)11.00811.47913.7498.8487.941

收益指标分析
经营活动净收益/利润总额(%)96.53091.83972.56082.75887.275
价值变动净收益/利润总额(%)2.82810.15525.65614.44516.796
营业外收支净额/利润总额(%)-2.577-1.872-2.626-3.501-3.184

偿债能力分析
流动比率 (X)1.4921.4851.2831.1671.282
速动比率 (X)1.2071.2111.0570.9661.082
资产负债率 (%)43.71544.48650.19255.79359.943
带息债务/全部投入资本 (%)32.93234.21940.18848.94654.435
股东权益/带息债务 (%)190.720179.446138.82197.36476.900
股东权益/负债合计 (%)109.449105.82383.16665.54854.742
利息保障倍数 (X)8.91112.11215.4594.4863.213

营运能力分析
应收账款周转天数 (天)125.909114.800115.106110.763111.114
存货周转天数 (天)99.88995.33893.42188.48491.009